ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08755
0,01%
Bitcoin
66.594,88
0,48%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSXV
  6. Cotec Holdings Corp (CTH)

  7. Cotec Holdings Corp (CTH) News

CTH

Cotec (CTH)

Cotec Holdings Corp
Von:
Sortieren nach:
 Showing the most relevant articles for your search:TSXV:CTH
DatumZeitQuelleÜberschriftSymbolFirma
19/11/201415h35PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - CTHTSXV:CTHCotec Holdings Corp
19/11/201415h33PR Newswire (Canada)IIROC Trading Resumption - CTHTSXV:CTHCotec Holdings Corp
18/11/201422h12PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - CTHTSXV:CTHCotec Holdings Corp
18/11/201422h10PR Newswire (Canada)IIROC Trading Halt - CTHTSXV:CTHCotec Holdings Corp
17/07/201422h15Marketwired CanadaCynapsus Therapeutics Commences Phase 2 Clinical Trials in the United StatesTSXV:CTHCotec Holdings Corp
08/07/201412h00Marketwired CanadaCynapsus Therapeutics Awarded Second Grant from The Michael J. Fox Foundation for Parkinson's ResearchTSXV:CTHCotec Holdings Corp
20/05/201422h42MarketwiredCynapsus Therapeutics Grants Stock OptionsTSXV:CTHCotec Holdings Corp
20/05/201422h42Marketwired CanadaCynapsus Therapeutics Grants Stock OptionsTSXV:CTHCotec Holdings Corp
14/05/201412h00MarketwiredCynapsus Announces No Buccal Mucosal Irritation in FDA Registration Study of APL-130277 for Parkinson's DiseaseTSXV:CTHCotec Holdings Corp
14/05/201412h00Marketwired CanadaCynapsus Announces No Buccal Mucosal Irritation in FDA Registration Study of APL-130277 for Parkinson's DiseaseTSXV:CTHCotec Holdings Corp
07/05/201423h30Marketwired CanadaCynapsus Therapeutics Reports First Quarter 2014 Financial Results and Recent DevelopmentsTSXV:CTHCotec Holdings Corp
07/05/201423h30MarketwiredCynapsus Therapeutics Reports First Quarter 2014 Financial Results and Recent DevelopmentsTSXV:CTHCotec Holdings Corp
24/04/201412h00MarketwiredCynapsus Announces Positive Results of CTH-104 Clinical Study of APL-130277 for Parkinson's DiseaseTSXV:CTHCotec Holdings Corp
24/04/201412h00Marketwired CanadaCynapsus Announces Positive Results of CTH-104 Clinical Study of APL-130277 for Parkinson's DiseaseTSXV:CTHCotec Holdings Corp
15/04/201416h56PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - CTHTSXV:CTHCotec Holdings Corp
15/04/201416h56PR Newswire (Canada)IIROC Trading Resumption - CTHTSXV:CTHCotec Holdings Corp
15/04/201416h27Marketwired CanadaCynapsus Therapeutics Completes $25,000,000 Short Form Prospectus OfferingTSXV:CTHCotec Holdings Corp
15/04/201414h19PR Newswire (Canada)IIROC Trading Halt - CTHTSXV:CTHCotec Holdings Corp
15/04/201414h19PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - CTHTSXV:CTHCotec Holdings Corp
09/04/201404h14Marketwired CanadaCynapsus Therapeutics Files Final Short Form ProspectusTSXV:CTHCotec Holdings Corp
28/03/201421h50Marketwired CanadaCynapsus Therapeutics Files Preliminary Short Form ProspectusTSXV:CTHCotec Holdings Corp
28/03/201411h00MarketwiredCynapsus Announces Interim Summary Results of Human Healthy Volunteer Single 25mg Study for APL-130277TSXV:CTHCotec Holdings Corp
28/03/201411h00Marketwired CanadaCynapsus Announces Interim Summary Results of Human Healthy Volunteer Single 25mg Study for APL-130277TSXV:CTHCotec Holdings Corp
27/03/201421h00MarketwiredCynapsus Therapeutics Reports 2013 Financial Results and Highlights Key DevelopmentsTSXV:CTHCotec Holdings Corp
27/03/201421h00Marketwired CanadaCynapsus Therapeutics Reports 2013 Financial Results and Highlights Key DevelopmentsTSXV:CTHCotec Holdings Corp
27/02/201415h22MarketwiredCynapsus Therapeutics Announces DTC ApprovalTSXV:CTHCotec Holdings Corp
27/02/201414h22Marketwired CanadaCynapsus Therapeutics Announces DTC ApprovalTSXV:CTHCotec Holdings Corp
13/02/201414h00MarketwiredCynapsus Therapeutics Appoints Nan Hutchinson to the Board of DirectorsTSXV:CTHCotec Holdings Corp
13/02/201413h00Marketwired CanadaCynapsus Therapeutics Appoints Nan Hutchinson to the Board of DirectorsTSXV:CTHCotec Holdings Corp
07/02/201415h15MarketwiredLifeSci Advisors Initiates Coverage of Cynapsus Therapeutics, Inc.TSXV:CTHCotec Holdings Corp
 Showing the most relevant articles for your search:TSXV:CTH

Kürzlich von Ihnen besucht

COIN
DOCKUST
Dock
TG
T15B
Tectonic Metals
TG
21P1
Aurora Cannabis
NASDAQ
KARO
Karooooo
BIT
UC4KT1
Unicredit Bank
AMEX
WGW
BIT
UC8AKS
Unicredit Bank
EU
JXRDS
Archos
BIT
UC41KR
Unicredit Bank
USOTC
IARGF
IAR Systems Group AB (PK)
NASDAQ
FGDTBX
Diversified High Income ...
EU
DGIRK
Departement de la Girond...
LATK
GTUSDT
GateChainToken
TSXV
RVV
Revive Therapeutics
EU
L168S
L168S
USOTC
ARGYF
Avanti Helium (PK)
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten